Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

類似資料

• Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
  著者:: Takeda Masayuki, 等
  出版事項: (2012-08-01)
• Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
  著者:: Takeda, Masayuki, 等
  出版事項: (2012)
• Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial
  著者:: Okamoto, Isamu, 等
  出版事項: (2020)
• Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib
  著者:: Takeda, Masayuki, 等
  出版事項: (2014)
• Clinical development of nintedanib for advanced non-small-cell lung cancer
  著者:: Takeda, Masayuki, 等
  出版事項: (2015)